North American Scientific's radiation oncology division, Nomos, has received approval in China to sell its flagship intensity modulated radiation therapy (IMRT) product for treating various cancers. The Peacock system consists of the firm's Corvus treatment planning software and its MIMiC multi-leaf collimator; sales of the equiptment could begin by the end of this month. Nomos is also in the process of registering in China its BAT family of products for image-guided radiation therapy, as well as Prospera I-125 brachytherapy seeds for treating prostate cancer.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?